UniProt ID | BMX_HUMAN | |
---|---|---|
UniProt AC | P51813 | |
Protein Name | Cytoplasmic tyrosine-protein kinase BMX | |
Gene Name | BMX | |
Organism | Homo sapiens (Human). | |
Sequence Length | 675 | |
Subcellular Localization | Cytoplasm . Localizes to the edges of spreading cells when complexed with BCAR1. | |
Protein Description | Non-receptor tyrosine kinase that plays central but diverse modulatory roles in various signaling processes involved in the regulation of actin reorganization, cell migration, cell proliferation and survival, cell adhesion, and apoptosis. Participates in signal transduction stimulated by growth factor receptors, cytokine receptors, G-protein coupled receptors, antigen receptors and integrins. Induces tyrosine phosphorylation of BCAR1 in response to integrin regulation. Activation of BMX by integrins is mediated by PTK2/FAK1, a key mediator of integrin signaling events leading to the regulation of actin cytoskeleton and cell motility. Plays a critical role in TNF-induced angiogenesis, and implicated in the signaling of TEK and FLT1 receptors, 2 important receptor families essential for angiogenesis. Required for the phosphorylation and activation of STAT3, a transcription factor involved in cell differentiation. Also involved in interleukin-6 (IL6) induced differentiation. Plays also a role in programming adaptive cytoprotection against extracellular stress in different cell systems, salivary epithelial cells, brain endothelial cells, and dermal fibroblasts. May be involved in regulation of endocytosis through its interaction with an endosomal protein RUFY1. May also play a role in the growth and differentiation of hematopoietic cells; as well as in signal transduction in endocardial and arterial endothelial cells.. | |
Protein Sequence | MDTKSILEELLLKRSQQKKKMSPNNYKERLFVLTKTNLSYYEYDKMKRGSRKGSIEIKKIRCVEKVNLEEQTPVERQYPFQIVYKDGLLYVYASNEESRSQWLKALQKEIRGNPHLLVKYHSGFFVDGKFLCCQQSCKAAPGCTLWEAYANLHTAVNEEKHRVPTFPDRVLKIPRAVPVLKMDAPSSSTTLAQYDNESKKNYGSQPPSSSTSLAQYDSNSKKIYGSQPNFNMQYIPREDFPDWWQVRKLKSSSSSEDVASSNQKERNVNHTTSKISWEFPESSSSEEEENLDDYDWFAGNISRSQSEQLLRQKGKEGAFMVRNSSQVGMYTVSLFSKAVNDKKGTVKHYHVHTNAENKLYLAENYCFDSIPKLIHYHQHNSAGMITRLRHPVSTKANKVPDSVSLGNGIWELKREEITLLKELGSGQFGVVQLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKQPYDLYDNSQVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MDTKSILEEL -----CCHHHHHHHH | 25.95 | 23898821 | |
5 | Phosphorylation | ---MDTKSILEELLL ---CCHHHHHHHHHH | 34.20 | 23898821 | |
22 | Phosphorylation | SQQKKKMSPNNYKER HHHCCCCCCCCHHHH | 33.10 | 24425749 | |
26 | Phosphorylation | KKMSPNNYKERLFVL CCCCCCCHHHHEEEE | 22.36 | 24425749 | |
34 | Phosphorylation | KERLFVLTKTNLSYY HHHEEEEECCCCCEE | 30.44 | 18785766 | |
40 | Phosphorylation | LTKTNLSYYEYDKMK EECCCCCEECHHHCC | 11.95 | 11331870 | |
120 | Phosphorylation | NPHLLVKYHSGFFVD CCCEEEEECCCEEEC | 8.17 | 23403867 | |
122 | Phosphorylation | HLLVKYHSGFFVDGK CEEEEECCCEEECCE | 33.92 | 23403867 | |
172 | Acetylation | TFPDRVLKIPRAVPV CCCHHHCCCCCCCCE | 48.05 | 7493313 | |
181 | Acetylation | PRAVPVLKMDAPSSS CCCCCEEECCCCCCC | 34.66 | 7493323 | |
186 | Phosphorylation | VLKMDAPSSSTTLAQ EEECCCCCCCCCHHH | 38.35 | - | |
202 | Phosphorylation | DNESKKNYGSQPPSS CCCCCCCCCCCCCCC | 27.34 | 22210691 | |
216 | Phosphorylation | SSTSLAQYDSNSKKI CCCCCEEECCCCCEE | 18.74 | 22817900 | |
224 | Phosphorylation | DSNSKKIYGSQPNFN CCCCCEEECCCCCCC | 21.43 | 12573241 | |
226 | Phosphorylation | NSKKIYGSQPNFNMQ CCCEEECCCCCCCCE | 26.03 | 23403867 | |
251 | Phosphorylation | WQVRKLKSSSSSEDV HHHCCCCCCCCCHHH | 45.98 | 24501219 | |
252 | Phosphorylation | QVRKLKSSSSSEDVA HHCCCCCCCCCHHHH | 32.43 | 23403867 | |
253 | Phosphorylation | VRKLKSSSSSEDVAS HCCCCCCCCCHHHHH | 45.00 | 23403867 | |
254 | Phosphorylation | RKLKSSSSSEDVASS CCCCCCCCCHHHHHC | 39.43 | 23403867 | |
255 | Phosphorylation | KLKSSSSSEDVASSN CCCCCCCCHHHHHCC | 39.50 | 23403867 | |
260 | Phosphorylation | SSSEDVASSNQKERN CCCHHHHHCCHHHHC | 29.66 | - | |
261 | Phosphorylation | SSEDVASSNQKERNV CCHHHHHCCHHHHCC | 33.28 | - | |
304 | Phosphorylation | FAGNISRSQSEQLLR HCHHCCHHHHHHHHH | 31.13 | 24501219 | |
324 | Phosphorylation | GAFMVRNSSQVGMYT CCEEEECCCCCEEEE | 16.16 | 23403867 | |
325 | Phosphorylation | AFMVRNSSQVGMYTV CEEEECCCCCEEEEE | 32.22 | 23403867 | |
330 | Phosphorylation | NSSQVGMYTVSLFSK CCCCCEEEEEEHHHH | 9.69 | - | |
336 | Phosphorylation | MYTVSLFSKAVNDKK EEEEEHHHHHHCCCC | 25.62 | 24719451 | |
337 | Acetylation | YTVSLFSKAVNDKKG EEEEHHHHHHCCCCC | 49.36 | 30588605 | |
343 | Acetylation | SKAVNDKKGTVKHYH HHHHCCCCCCEEEEE | 63.78 | 30588611 | |
347 | Acetylation | NDKKGTVKHYHVHTN CCCCCCEEEEEEEEC | 37.98 | 30588617 | |
365 | Phosphorylation | KLYLAENYCFDSIPK CEEEEHHHCCCCHHH | 5.99 | 22817900 | |
394 | Phosphorylation | RLRHPVSTKANKVPD ECCCCCCCCCCCCCC | 34.12 | 23911959 | |
395 | Acetylation | LRHPVSTKANKVPDS CCCCCCCCCCCCCCC | 42.32 | 19821499 | |
412 | Ubiquitination | LGNGIWELKREEITL CCCCHHHCHHHEEHH | 3.68 | 22817900 | |
413 | Ubiquitination | GNGIWELKREEITLL CCCHHHCHHHEEHHH | 46.37 | 22817900 | |
425 | Phosphorylation | TLLKELGSGQFGVVQ HHHHHHCCCCCEEEE | 41.88 | - | |
440 | Phosphorylation | LGKWKGQYDVAVKMI EECCCCCEEEEEEEH | 22.51 | - | |
553 | Phosphorylation | RDLCVKVSDFGMTRY CCCEEEEHHCCCEEE | 22.85 | 23879269 | |
558 | Phosphorylation | KVSDFGMTRYVLDDQ EEHHCCCEEEEECCC | 21.16 | 23879269 | |
560 | Phosphorylation | SDFGMTRYVLDDQYV HHCCCEEEEECCCCC | 9.01 | 23879269 | |
566 | Phosphorylation | RYVLDDQYVSSVGTK EEEECCCCCCCCCCC | 14.86 | 10688651 | |
568 | Phosphorylation | VLDDQYVSSVGTKFP EECCCCCCCCCCCCC | 17.86 | - | |
569 | Phosphorylation | LDDQYVSSVGTKFPV ECCCCCCCCCCCCCC | 17.96 | 23879269 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
216 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
216 | Y | Phosphorylation | Kinase | BTK | Q06187 | PSP |
216 | Y | Phosphorylation | Kinase | ITK | Q08881 | PSP |
216 | Y | Phosphorylation | Kinase | TEC | P42680 | PSP |
224 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
224 | Y | Phosphorylation | Kinase | BTK | Q06187 | PhosphoELM |
224 | Y | Phosphorylation | Kinase | TEC | P42680 | PhosphoELM |
566 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
566 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
566 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BMX_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BMX_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PTN21_HUMAN | PTPN21 | physical | 11013262 | |
CAV1_HUMAN | CAV1 | physical | 11751885 | |
FAK1_HUMAN | PTK2 | physical | 11331870 | |
RUFY1_HUMAN | RUFY1 | physical | 11877430 | |
RUFY2_HUMAN | RUFY2 | physical | 11877430 | |
SRC_HUMAN | SRC | physical | 10688651 | |
STAT3_HUMAN | STAT3 | physical | 10688651 | |
PAK1_HUMAN | PAK1 | physical | 11382770 | |
A4_HUMAN | APP | physical | 21832049 | |
CL045_HUMAN | C12orf45 | physical | 21988832 | |
STAT3_HUMAN | STAT3 | physical | 25416956 | |
STAT3_HUMAN | STAT3 | physical | 21516116 | |
C2D1B_HUMAN | CC2D1B | physical | 28514442 | |
UBP24_HUMAN | USP24 | physical | 28514442 | |
ARI2_HUMAN | ARIH2 | physical | 28514442 | |
WIPI3_HUMAN | WDR45B | physical | 28514442 | |
PDD2L_HUMAN | PDCD2L | physical | 28514442 | |
CSN8_HUMAN | COPS8 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Etk, a Btk family tyrosine kinase, mediates cellular transformationby linking Src to STAT3 activation."; Tsai Y.T., Su Y.H., Fang S.S., Huang T.N., Qiu Y., Jou Y.S.,Shih H.M., Kung H.J., Chen R.H.; Mol. Cell. Biol. 20:2043-2054(2000). Cited for: PHOSPHORYLATION AT TYR-566, MUTAGENESIS OF TYR-566, FUNCTION, ANDINTERACTION WITH STAT3. | |
"Identification of phosphorylation sites within the SH3 domains of Tecfamily tyrosine kinases."; Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.; Biochim. Biophys. Acta 1645:123-132(2003). Cited for: PROTEIN SEQUENCE OF 207-220 AND 223-236, AND PHOSPHORYLATION ATTYR-216 AND TYR-224. |